Literature DB >> 33402217

Hypoglycemic episodes in hospitalized people with diabetes in Portugal: the HIPOS-WARD study.

Sílvia Alão1, João Conceição2, Jorge Dores3, Lèlita Santos4,5, Francisco Araújo6, Estevão Pape7, Mónica Reis8, Árcia Chipepo6, Edite Nascimento9, Ana Baptista10, Vanessa Pires11, Carlos Marques12, Adriana De Sousa Lages4, João Pelicano-Romano13, Paula M de Jesus13.   

Abstract

BACKGROUND: We intended to estimate the proportion hypoglycemic/hyperglycemic emergency episodes in treated diabetes mellitus (DM) patients admitted to a hospital ward, and calculate the prevalence of risk factors for hypoglycemia and diabetic complications.
METHODS: In this cross-sectional, multicentered study, the observational data was collected by physicians from patient's hospitalization to discharge/death. Statistical tests were 2-tailed considering 5% significance level.
RESULTS: There were 646 ward admissions due to hyperglycemic emergencies and 176 hypoglycemic episodes with a ratio hypoglycemia/hyperglycemia 0.27 for all DM patients. In T2DM patients the ratio was 0.38. These were mainly female (55.1%), functionally dependent (61.4%) and retired/disabled (73.1%). Median age was 75 years and median duration of disease 11 years. Half the patients were on insulin-based therapy and 30.1% on secretagogue-based therapy. Approximately 57% of patients needed occasional/full assistance to manage the disease. The most frequent risk factor for hypoglycemia was polypharmacy (85.0%). Hypoglycemia in the 12 months before admission was higher in insulin-based therapy patients (66.1%; p = 0.001).
CONCLUSIONS: Hyperglycemic emergencies are the most frequent cause of hospitalization in Portugal, although severe hypoglycemic events represent a health and social problem in elderly/frail patients. There is still the need to optimize therapy in terms of the potential for hypoglycemia in this patient group and a review of anti-hyperglycemic agents to add on to insulin.

Entities:  

Keywords:  Diabetes; Hypoglycemic episodes; Inpatients

Year:  2021        PMID: 33402217      PMCID: PMC7786902          DOI: 10.1186/s40842-020-00114-3

Source DB:  PubMed          Journal:  Clin Diabetes Endocrinol        ISSN: 2055-8260


  35 in total

Review 1.  Drug-induced hypoglycaemia in type 2 diabetes.

Authors:  Berit Inkster; Nicola N Zammitt; Brian M Frier
Journal:  Expert Opin Drug Saf       Date:  2012-06-13       Impact factor: 4.250

2.  Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

Authors:  Elizabeth R Seaquist; John Anderson; Belinda Childs; Philip Cryer; Samuel Dagogo-Jack; Lisa Fish; Simon R Heller; Henry Rodriguez; James Rosenzweig; Robert Vigersky
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

3.  Hypoglycemia.

Authors:  Javier Morales; Doron Schneider
Journal:  Am J Med       Date:  2014-10       Impact factor: 4.965

4.  Real-world prevalence of mild to moderate hypoglycemic episodes in type 2 diabetes in Portugal: Results from the HIPOS-PHARMA study.

Authors:  Carla Torre; José Pedro Guerreiro; Sónia Romano; Ana Miranda; Patrícia Longo; Sílvia Alão; João Conceição; Pedro Laires
Journal:  Prim Care Diabetes       Date:  2018-07-17       Impact factor: 2.459

5.  The cost of managing severe hypoglycemic episodes in Type 2 diabetic patients.

Authors:  Pedro Almeida Laires; João Conceição; Francisco Araújo; Jorge Dores; Catarina Silva; Larry Radican; Ana Nogueira
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2015-09-07       Impact factor: 2.217

6.  National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.

Authors:  Kasia J Lipska; Joseph S Ross; Yun Wang; Silvio E Inzucchi; Karl Minges; Andrew J Karter; Elbert S Huang; Mayur M Desai; Thomas M Gill; Harlan M Krumholz
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

7.  HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.

Authors:  Marcus Lind; Aldina Pivodic; Ann-Marie Svensson; Arndis F Ólafsdóttir; Hans Wedel; Johnny Ludvigsson
Journal:  BMJ       Date:  2019-08-28

Review 8.  Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes.

Authors:  Bo Ahrén
Journal:  Vasc Health Risk Manag       Date:  2013-04-24

9.  Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetes Care       Date:  2018-10-04       Impact factor: 19.112

10.  Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach.

Authors:  João P Ferreira; Francisco Araújo; Jorge Dores; Lèlita Santos; Estevão Pape; Mónica Reis; Árcia Chipepo; Edite Nascimento; Ana Baptista; Vanessa Pires; Carlos Marques; Adriana S Lages; João Conceição; Pedro A Laires; João Pelicano-Romano; Sílvia Alão
Journal:  Diabetes Ther       Date:  2020-07-11       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.